Akari Therapeutics plc (AKTX) insider trading
Every open-market stock purchase and sale by Akari Therapeutics plc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $2.9M over the last 12 months (8 buys).
- Last insider buy: Hoyoung Huh (10% owner), $1.2M, 10 months ago.
Last 12 months: insiders bought $2.9M (8 buys) and sold $0 (0 sales). Last close $8.10 on Oct 22, 2026.
Recent AKTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 14, 2026 | Abizer Gaslightwala (CEO) | Bought (not open market) | $312K |
| Oct 14, 2026 | Abizer Gaslightwala (CEO) | Bought (not open market) | $125K |
| Oct 14, 2026 | Sandip I Patel (Director) | Bought (not open market) | $100K |
| Oct 14, 2026 | Sandip I Patel (Director) | Bought (not open market) | $62.5K |
| Oct 14, 2026 | Robert B Bazemore (Director) | Bought (not open market) | $50K |
| Oct 14, 2026 | Robert B Bazemore (Director) | Bought (not open market) | $12.5K |
| Oct 14, 2026 | Abizer Gaslightwala (CEO) | Bought (not open market) | $8 |
| Oct 14, 2026 | Abizer Gaslightwala (CEO) | Bought (not open market) | $3 |
| Oct 14, 2026 | Sandip I Patel (Director) | Bought (not open market) | $2 |
| Oct 14, 2026 | Sandip I Patel (Director) | Bought (not open market) | $2 |
| Oct 14, 2026 | Robert B Bazemore (Director) | Bought (not open market) | $1 |
| Oct 14, 2026 | Robert B Bazemore (Director) | Bought (not open market) | $0 |
| Oct 12, 2026 | Vatnak Vat-Ho (C-suite exec) | Bought (not open market) | — |
| Oct 5, 2026 | Hoyoung Huh (10% owner) | Bought (not open market) | $48.7K |
| Oct 5, 2026 | Robert B Bazemore (Director) | Bought (not open market) | $36.9K |
| Oct 5, 2026 | Sandip I Patel (Director) | Bought (not open market) | $34.1K |
| Oct 5, 2026 | Raymond Prudo-Chlebosz (Director) | Bought (not open market) | $25.6K |
| Oct 5, 2026 | Samir Rashmikant Patel (Director) | Bought (not open market) | $17.7K |
| Sep 29, 2026 | Abizer Gaslightwala (CEO) | Bought (not open market) | $62.5K |
| Aug 18, 2026 | Hoyoung Huh (10% owner) | Bought (not open market) | $136K |
| Aug 18, 2026 | Robert B Bazemore (Director) | Bought (not open market) | $103K |
| Aug 18, 2026 | Sandip I Patel (Director) | Bought (not open market) | $95.6K |
| Aug 18, 2026 | Raymond Prudo-Chlebosz (Director) | Bought (not open market) | $71.7K |
| Aug 18, 2026 | Samir Rashmikant Patel (Director) | Bought (not open market) | $49.8K |
| Aug 18, 2026 | Sandip I Patel (Director) | Bought (not open market) | — |
Who's trading AKTX
- Robert B Bazemore, Director: bought $62.5K (2 buys), last Oct 14, 2026
- Sandip I Patel, Director: bought $162K (2 buys), last Oct 14, 2026
- Abizer Gaslightwala, CEO: bought $437K (2 buys), last Oct 14, 2026
- Vatnak Vat-Ho, C-suite exec: other filings, last Oct 12, 2026
- Hoyoung Huh, 10% owner: bought $1.5M (2 buys), last Oct 5, 2026
- Samir Rashmikant Patel, Insider: bought $344K (2 buys), last Oct 5, 2026
- Raymond Prudo-Chlebosz, Director: bought $406K (2 buys), last Oct 5, 2026
- Kameel D. Farag, CFO: bought $10K (1 buy), last Aug 17, 2026
- James R Neal, Insider: bought $2.2K (2 buys), last Dec 16, 2025
Get free alerts when an insider at Akari Therapeutics plc files a new trade →